Since overexpression of PTCHD4-AS can activate MMR by promoting MSH2-MSH6 dimerization, it may enhance the cytotoxicity of cisplatin to GC cells, which was experimentally confirmed in this study. The gene discussed is MSH2; the disease is gastric cancer.